Search
for
Sort by
Research 211–240 of 1000+
- An <i>in Vitro</i> Model for the Study of Human Hair Growth
- Unravelling the link between insulin resistance and androgen excess
- Vitamin D metabolism and function in the skin
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Estrogen and androgen signaling in the pathogenesis of BPH
- Coactivator MED1 Ablation in Keratinocytes Results in Hair-Cycling Defects and Epidermal Alterations
- Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
- Non-viral delivery of the CRISPR/Cas system: DNA<i>versus</i>RNA<i>versus</i>RNP
- The 1,25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms
- Drug Repurposing Patent Applications July–September 2025
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Androgen receptors and their biology
- 9 Role of 5α-reductase in health and disease
- Nanotechnology-based techniques for hair follicle regeneration
- Redefining hormone resistance in prostate cancer
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Gene Therapy: Recent Advances and Applications in Dermatology
- Regulation of masculinization: androgen signalling for external genitalia development
- Extraskeletal actions of vitamin D
- Low-level light therapy (LLLT) for cosmetics and dermatology
- INTERFERONS IN DERMATOLOGY
- Benign Cutaneous Eruptions After Transplantation
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- Clinical and biological impact of the exposome on the skin
- Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium
- Pharmacological Options for Treatment of Hyperandrogenic Disorders